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In the fifty years since its discovery, a substantial body
of work has established that nerve growth factor plays
a key role in promoting the survival of neurons during
development; the recent demonstration that it can also
promote cell death therefore comes as a surprise.
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Work on nerve growth factor (NGF) laid the foundations
for the neurotrophic theory, the idea that the survival of
developing neurons is dependent on a supply of a neu-
rotrophic factor from the tissues they innervate. Classic
studies of the effects of manipulating the availability of
NGF to neurons in the developing nervous system
demonstrated that the survival of sympathetic neurons
and certain kinds of sensory neurons is dependent on a
supply of NGF. Accordingly, these same neurons are
eliminated in mice that have targeted null mutations in
either the NGF gene or the trkA gene which codes for the
tyrosine kinase-type NGF receptor (reviewed in [1,2]). 
NGF is the founder member of a family of proteins
termed the neurotrophins; the family includes brain-
derived neurotrophic factor (BDNF), neurotrophin-3
(NT3), NT4/5 and NT6. A wealth of studies in vitro and
in vivo of the effects of these proteins on neurons, and
studies of mice with targeted null mutations in genes
coding for these proteins and their receptors, have
extended the generality of the neurotrophic hypothesis. In
addition, such studies have revealed several other roles for
neurotrophins, including promoting the survival, prolifera-
tion and differentiation of certain neuronal progenitor cells
and influencing synaptic function. There is also some
evidence that, at certain stages of development, neuro-
trophins act on some neurons by an autocrine route [1,2].
Although there have been a few reports that NGF admin-
istration can reduce the size of certain neuronal popula-
tions in vivo [3–5], the recent striking demonstration that
anti-NGF antiserum reduces cell death in the developing
eye [6] and that NGF kills oligodendrocytes in culture [7]
has focused attention on the potential physiological signif-
icance of cytotoxic actions of NGF.
Neurotrophin receptors
To understand the complementary neurotrophic and
cytotoxic functions of NGF, it is necessary first to consider
the properties of neurotrophin receptors. Two kinds of
transmembrane glycoproteins are receptors for neuro-
trophins: members of the Trk family of receptor tyrosine
kinases, each of which acts as a receptor for a different
neurotrophin or subset of neurotrophins, and p75, which is
a common receptor for all neurotrophins [8]. The pattern
of expression of these receptors in neurons differs:
whereas each Trk receptor is restricted to particular sets of
neurons, p75 is usually co-expressed with Trks in many
different kinds of neuron.
Trk receptor tyrosine kinases undergo rapid trans-
phosphorylation following ligand binding, leading to a
cascade of protein phosphorylations in the cell. Expression
studies in cell lines have shown that TrkA is a receptor for
NGF, TrkB is a receptor for BDNF and NT4/5, and TrkC
is a receptor for NT3. NT3 can also bind and signal less
efficiently via TrkA and TrkB [8]. The finding that the
distinctive neuronal deficiencies in mice with null muta-
tions in the trkA, trkB and trkC genes are similar to those
observed in mice with null mutations in the NGF, BDNF
and NT3 genes, respectively, suggests that Trks mediate
the survival-promoting actions of neurotrophins on devel-
oping neurons [1,2].
The functions of p75 are more diverse and complex than
those of the Trks. Studies in vitro of neurons obtained from
p75-null mice have shown that p75 is not required for the
survival response of neurons to neurotrophins. However,
the response of p75-deficient embryonic sensory and post-
natal sympathetic neurons to NGF requires higher than
normal NGF concentrations, suggesting that p75 specifi-
cally enhances the sensitivity of NGF-dependent neurons
to NGF [9,10]. Interestingly, the sensitivity of neurons to
other neurotrophins is not reduced in p75-deficient
neurons. These findings accord with the overall phenotype
of p75 null mice, which is consistent with a partial loss of
NGF-dependent sensory and sympathetic neurons [11,12].
The p75 receptor also plays a role in ligand discrimination
by the Trk receptors. The ability of NT3 to activate TrkA
in the PC12 phaeochromocytoma cell line is enhanced
when the binding of NT3 to p75 is prevented by function-
perturbing antibodies, or when p75 expression is very low
[13,14]. Likewise, sympathetic neurons from postnatal
p75-deficient mice are more sensitive to NT3 than sympa-
thetic neurons from wild-type animals [10]. These findings
suggest that p75 reduces the ability of NT3 to signal via
TrkA. Furthermore, studies with mutated BDNF and
NT4/5 proteins that bind TrkB normally but fail to bind
p75 suggest that p75 also plays a role in TrkB ligand
discrimination. Whereas the BDNF mutant activates TrkB
as effectively as does wild-type BDNF, the NT4/5 mutant
activates TrkB less effectively than wild-type NT4/5 [15].
In addition to the evidence that p75 selectively modulates
the trophic actions of neurotrophins in neurons expressing
different Trk receptors, several experimental findings
suggest that p75 is able to promote cell death in the
absence of ligand (see Fig. 1). In a neuron-like cell line
and in PC12 cells grown without NGF (in serum-free con-
ditions), p75 expression increases the rate of cell death
[16]. Antisense p75 oligonucleotides that reduce p75
levels promote the survival of postnatal rat dorsal root gan-
glion (DRG) neurons grown in the absence of NGF, sug-
gesting that at this stage of development p75 is able to act
as a constitutive death signal in the absence of NGF [17].
In the fetal period, antisense p75 oligonucleotides do not
rescue DRG neurons grown in the absence of NGF but do
reduce the survival-promoting effects of NGF, suggesting
that there is a developmental switch in the role of p75
from its participation in enhancing the survival-promoting
action of NGF in the fetal period to promoting neuronal
death in the absence of ligand postnatally [17].
NGF-dependent p75 cytotoxicity
In contrast to the apparent ligand-independent cytotoxic
actions of p75 [16,17], two reports [6,7] have now provided
evidence for p75 cytotoxicity triggered by NGF binding.
In the first study [6], anti-NGF antibodies, or antibodies
that block binding of NGF to p75, caused a marked reduc-
tion in the number of cells that undergo apoptosis in the
chicken embryo retina before retinal axons begin innervat-
ing the tectum. At this early stage of development, NGF is
expressed in the retina and the great majority of cells that
normally undergo apoptosis express p75 but not TrkA.
This suggests that NGF produced within the retina prom-
otes cell death by binding to p75. In this experimental
paradigm, however, NGF administration did not increase
the number of cells undergoing apoptosis. This suggests
that p75 expression is not sufficient for NGF-mediated
cytotoxicity because p75 is expressed by more cells in the
early retina than undergo apoptosis [6]. Likewise,
Schwann cells express p75 without TrkA, yet NGF does
not kill these cells but stimulates their migration [18].
The second recent study [7] showed that NGF causes rapid
death of mature oligodendrocytes in culture. These cells
express p75 without TrkA, and the cytotoxic effects of
NGF are prevented by an antibody that binds to the extra-
cellular domain of p75, suggesting that p75 mediates these
effects. Interestingly, although BDNF and NT3 bind to
p75 with similar affinity to that of NGF, neither of these
ligands induces apoptosis in mature oligodendrocytes [7].
In addition to these demonstrations of p75-mediated NGF
cytotoxicity, several previous studies have shown that NGF
administration can reduce the size of certain neuronal popu-
lations in the central nervous system. First, application of
NGF to lesioned sciatic and facial nerves increases the
number of motoneurons that undergo cell death following
lesion [3,4], whereas BDNF administration prevents facial
motoneuron death [4]. Although there is prominent p75
expression in motoneurons following axotomy [19], the role
of p75 in mediating the cytotoxic effects of NGF has yet to
be tested in these lesion models. Second, during the period
of naturally occurring neuronal death in the embryonic
chicken isthmo-optic nucleus (ION), a population of mid-
brain neurons that innervates the retina, systemic or intraoc-
ular administration of NGF increases neuronal death in a
dose-dependent manner [5]. Administration of either
BDNF or NT3 at this time reduces neuronal death in the
ION, raising the possibility that developing ION neurons
are normally dependent on these neurotrophins for survival. 
Although developing ION neurons express p75, the role of
p75 in mediating the neurotoxic effects of NGF in these
cells is unclear. Intraocular administration of antibodies
against the extracellular domain of p75 increases neuronal
death in the ION [5], whereas these same antibodies
decrease cell death within the retina when administered
Dispatch R39
Figure 1
Summary of the effects of NGF and its p75 receptor on cell survival or death. See text for details.
NGF TrkA and p75 Sympathetic and some sensory neurons Survival
None p75 PC12 cell line and postnatal DRG neurons Death
NGF p75 Embryonic retinal neurons
NGF p75 Oligodendrocytes
Death
Death
Neurotrophin Receptor Cell type Survival or death
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earlier in development [6] and inhibit the cytotoxic effects
of NGF on mature oligodendrocytes in culture [7].
Because p75 has been implicated in retrograde axonal
transport of neurotrophins [20], it is feasible that the
increased loss of ION neurons following intraocular
administration of anti-p75 antibodies could have been due
to interference with axonal transport of endogenous
BDNF or NT3 from the retina to the ION.
How does p75 promote apoptosis
The p75 receptor is a member of a family that includes the
receptor for tumour necrosis factor (TNF). Several recent
studies have defined the signal transduction mechanism that
leads to apoptosis following activation of another member of
this family, called Fas. Binding of the Fas ligand triggers an
interaction between an 80 amino-acid ‘death domain’ within
the cytoplasmic portion of Fas and a similar domain in a
cytoplasmic protein called FADD/MORT1. This in turn
recruits another protein called FLICE/MACH which initi-
ates a protease cascade that causes apoptosis (reviewed in
[21]). The p75 sequence also includes a cytoplasmic ‘death
domain’, although it is not known if NGF binding results in
a similar signal transduction mechanism leading to apoptosis
in cells that are susceptible to the cytotoxic effects of NGF. 
Binding of NGF, but not BDNF or NT3, to p75 in mature
oligodendrocytes leads to an elevation of intracellular levels
of the lipid signalling molecule ceramide [7]. Ceramide is
also generated by binding of the Fas ligand to Fas, and by
the binding of TNFa to the TNFR1 receptor, events
which lead to apoptosis in certain cell types. This, together
with the finding that ceramide treatment induces apoptosis
in many cells, suggests that ceramide plays a role in mediat-
ing apoptosis [22]. However, the link between ceramide
production and apoptosis is not clear-cut. Elevated intracel-
lular ceramide levels following receptor activation do not
always lead to apoptosis, and there is evidence that
ceramide treatment can prevent sympathetic neurons from
undergoing apoptosis following NGF deprivation [23].
In addition to the long-recognized role of NGF in promoting
neuronal survival, the recent work described here has clearly
shown that NGF can also promote cell death. These oppos-
ing actions of NGF are due, at least in part, to the kinds of
receptor expressed by responsive cells. NGF promotes
neuronal survival by signalling via TrkA. Co-expression of
p75 with TrkA under these circumstances enhances the sur-
vival-promoting effects of NGF. In the absence of TrkA,
NGF signalling via p75 may promote apoptosis. However,
because NGF activation of p75 does not always cause apop-
tosis in the absence of Trk signalling, it will be important to
define and compare the events downstream from p75 in
cells that are killed by NGF and those that are not.
The demonstration of NGF-dependent, p75-mediated
cytotoxicity in the early avian retina and in cultured mature
oligodendrocytes raises the question of whether p75-medi-
ated NGF cytotoxicity regulates the size of other cell pop-
ulations as well. Detailed studies of mice with null
mutations in the NGF and p75 genes will be helpful in this
respect, and will reveal whether NGF signalling via p75
promotes apoptosis in the early mammalian retina, and
whether p75 signalling plays a role in regulating mature
oligodendrocyte survival in vivo. Studies in vitro of post-
natal sensory neurons obtained from p75-deficient animals
will also provide a valuable test of the ligand-independent
cytotoxic role proposed for p75 in these neurons.
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